All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date Terminated||2014-005523-27||Multicenter prospective randomized trial of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosis Estudio prospectivo multicéntric...||bad-data|
|Completed, but no date||2015-004238-85||Ictal brain SPECT in the premotor stage of Parkinson disease SPECT Ictal de perfusión cerebral en el periodo premotor de la enfermedad de Parkinson||bad-data|
|Ongoing||2016-000347-14||Cell proliferation in pulmonary hypertension: mollecular imaging detection by FDG PET. Comparative study between patients and healthy subjects Proliferación celular en la hipertensión pulmonar: Det...||not-yet-due|
|Exempt||2016-002972-29||Pilot study on the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B...||not-yet-due|
|Not reported Terminated||2016-003451-30||Subjects with subjective cognitive decline: 18F-Florbetaben Positrón Emission Tomography Study. Estudio de sujetos con deterioro cognitivo subjetivo: estudio con Tomografía por Emisión de Positrone...||2019-02-28||due-trials|
|Reported results||2016-004499-23||Safety and tolerability of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis: a multicenter, double-blind, placebo controlled randomized clinical trial.||2018-03-12||due-trials|
|Listed as ongoing, but also has a completion date||2018-001698-25||Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis to prevent ACLF development: a multicenter, double-blind, placebo controlled randomized clinical tria...||2022-12-01||bad-data|
|Ongoing||2019-003038-17||Phase 2 study of the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A...||not-yet-due|
|Ongoing||2020-006023-33||Efficacy of simvastatin reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled clinical trial. Eficacia de la simvastatina para r...||not-yet-due|
|Ongoing||2021-001288-26||Safety, tolerance and antiretroviral activity of dasatinib: a pilot clinical trial in patients with recent HIV-1 infection Seguridad, tolerancia y actividad antirretroviral de dasatinib: estudio cl...||not-yet-due|
|Ongoing||2022-000358-26||Safety, tolerability, and efficacy of a dose reduction strategy based on bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV-infected adults. Seguridad, tolerabilidad y ...||not-yet-due|